Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home
IBRANCE® (palbociclib)
MENU
BACK

Main navigation

  • NEWLY DIAGNOSED
  • ABOUT IBRANCE
    • OVERVIEW
    • STARTING AND TAKING IBRANCE
  • PATIENT SUPPORT RESOURCES
    • TALKING WITH YOUR DOCTOR
    • CONNECTING WITH OTHERS WHO UNDERSTAND
    • TIPS ON LIVING WITH ADVANCED BREAST CANCER
    • HELPFUL TERMINOLOGY
    • DOWNLOAD FREE RESOURCES
    • LATEST ARTICLES
  • FAMILY AND FRIENDS SUPPORT
  • HEALTHCARE PROFESSIONAL

Breadcrumb

  1. Home
  2. Site Map

Site Map

  • NEWLY DIAGNOSED
  • ABOUT IBRANCE
  • OVERVIEW
  • STARTING AND TAKING IBRANCE
  • PATIENT SUPPORT RESOURCES
  • TALKING WITH YOUR DOCTOR
  • CONNECTING WITH OTHERS WHO UNDERSTAND
  • TIPS ON LIVING WITH ADVANCED BREAST CANCER
  • HELPFUL TERMINOLOGY
  • DOWNLOAD FREE RESOURCES
  • LATEST ARTICLES
  • FAMILY AND FRIENDS SUPPORT
  • HEALTHCARE PROFESSIONAL
IBRANCE has switched from capsules to tablets.
Click here to see how this change further supports you.
 

Footer menu

  • Terms of use
  • Privacy Policy
  • Contact Pfizer
  • Site Map

IBRANCE® (palbociclib 75 mg, 100 mg and 125 mg) Capsules and Tablets

IBRANCE (palbociclib) is a funded prescription medicine used to treat HR+, HER2- advanced breast cancer taken in combination with an aromatase inhibitor or fulvestrant. IBRANCE has risks and benefits. Do not take IBRANCE if you are allergic to palbociclib or any of the other ingredients in IBRANCE capsules or IBRANCE tablets.

Caution is needed if you are premenopausal or perimenopausal, have or have had abnormal blood test results, respiratory infections or problems with your lungs, problems with your liver or kidneys, are lactose intolerant, are pregnant or planning to become pregnant or are breastfeeding. Tell your doctor if you are taking any other medicines. Common side effects include infection, abnormal blood test results, tiredness, feeling sick or vomiting, diarrhoea, sore mouth, lips or tongue, hair loss, loss of appetite, nose bleed, skin rash, change in sense of taste, blurred vision, increased tearing or dry eyes, shortness of breath, bleeding or bruising more easily than usual. If symptoms continue or you have side effects, see your doctor, pharmacist or healthcare professional. Ask your doctor if IBRANCE is right for you. Use strictly as directed. Contains 75 mg, 100 mg or 125 mg of palbociclib. IBRANCE is funded. A pharmacy charge and normal doctor’s fees apply for all prescriptions.

Further information on IBRANCE is available from Medsafe www.medsafe.govt.nz or Pfizer New Zealand Limited, Auckland, www.pfizer.co.nz Ph. 0800 736 363.V10721

Copyright © 2021 Pfizer New Zealand Limited. All rights reserved. IBRANCE® is a registered trademark.

Pfizer New Zealand Limited, Auckland Last Updated: February 2022. PP-IBR-NZL-0189. TAPS NP 20139

logo

Disclaimer: You are now leaving IBRANCE.co.nz. The information on the external website may not comply with the New Zealand legislation or advertising codes. Further information relevant to the New Zealand environment is available from Pfizer’s website www.pfizer.co.nz.

Cancel CONTINUE

Disclaimer: You are now leaving Ibrance.co.nz to another Pfizer website. Further information relevant to the New Zealand environment is available from the Pfizer website www.Pfizer.co.nz.

Cancel CONTINUE